Skip to content
email-marketing-gb64593361_1920

November 2025 Update

Formal request for clarity regarding the vote of no confidence in the GPCE chair

In October, Doncaster LMC raised a formal request with the BMA Council, seeking transparency around recent events within GPCE and the handling of contract negotiations. The request, submitted on 8 October and passed to GPCE on 23 October, has yet to receive any acknowledgement or substantive response. This silence has become increasingly concerning, particularly in light of questions about whether the GPCE Executive misled both its own committee and LMCs.

The request asked for clarity on whether a vote of confidence in the GPCE Chair was formally tabled, who initiated it, and what the outcome was. It also sought details on what actions have been taken since that vote and how these have been communicated to the wider profession. Alongside this, Doncaster LMC pressed for an explanation of the BMA’s current position on the October contract changes. Many GPs will recall how the narrative shifted from questioning the legitimacy of the negotiation process to accepting the contract as unilaterally imposed. Dr Eggitt asked what internal discussions led to the declaration of formal dispute with government, and whether the promised funding and ten‑year plan referenced back in February have been substantiated or revisited.

The lack of transparency has left LMCs uncertain about the integrity of our representative structures and the strategic direction being pursued. As statutory bodies, we have a duty to ensure that decisions made on behalf of grassroots GPs are subject to scrutiny, accountability, and clear communication. Doncaster LMC has therefore asked for confirmation of how these concerns will be addressed, and where a formal complaint could be submitted for investigation if necessary.

This ongoing request highlights the importance of openness in representation and the need for clear answers to safeguard trust in the structures that speak for us all.

Memory Clinic Update

Following concerns raised by GPs regarding the recent pattern of referral rejections from the Memory Clinic service the LMC has written to RDaSH outlining the issues.

Colleagues have reported multiple instances where referrals have been declined for reasons not clearly outlined in the referral documentation. These include:

  • Recent hospital admission, despite discharge summaries recommending memory clinic referral
  • Prior referral to talking therapies
  • Alleged omission of the 6CIT score, which had in fact been included

These inconsistencies have been causing understandable frustration and risk delaying timely assessment and support for patients with suspected cognitive impairment. The lack of transparent exclusion criteria on the referral form compounds the issue, leading to duplicated clinical work and potential gaps in care.

On behalf of colleagues, the LMC asked the following questions:

  1. Clarify the current triage criteria and any exclusion thresholds used by the service
  2. Confirm whether recent hospitalisation or talking therapy involvement are considered grounds for rejection
  3. Review the referral form to ensure it reflects all necessary information and exclusions
  4. Consider a joint discussion with primary care representatives to improve mutual understanding and reduce avoidable rejections

Response to the questions below:

  • Ahead of referral criteria is based on the presenting patient expressing concern regarding their memory including onset, length of history (lasting 6 months or more) and progression and impact of daily life. Primary Care would be expected to exclude any treatable illnesses and review any medication to identify any which may impair cognitive function. Exclusion criteria would apply to patients who have experienced delirium within the previous 3 months including urinary tract infections, chest infection, constipation, dehydration etc. This waiting period is to ensure that the patient returns to their optimum level. Recommended dementia blood screens should be taken and reviewed before referral: to rule out metabolic and endocrine Disorders
    Hypothyroidism
    Vitamin B12 deficiency
    Vitamin D deficiency*
    Folate deficiency
    Hypercalcemia or hypocalcaemia
    Electrolyte imbalances
    A cognitive screening e.g. 6CIT should also be completed.  Scores of 0-7 are considered normal 8 or more significant and evidence of 6CIT

 

  • Referrals will be triaged by a senior member of the RDASH team, including team managers and healthcare professionals. The referral will be reviewed to look for the following information:
    • Presenting problem (e.g., various ways dementia can present, such as memory loss, confusion, mood changes, or behavioural disturbances)
    • What work has been completed to rule out pseudo-dementia (conditions that mimic dementia, like depression or medication effects)
    • If essential we will contact the patient or their next of kin, to obtain further information
    • At this stage to referral is accepted or declined.
    • Hospitalisation would only be an excluding factor if the criteria above is applied. Talking Therapy involvement is not considered grounds for a rejected referral.

A review of RDASH’s referral form is underway by RDASH’s Service Manager to ensure that this reflects all necessary information and exclusions.

Join RDaSH for lunch on 26 November

Here is your invitation to join our Learning Disability and Forensic Teams for lunch on Wednesday, 26 November between 1 and 2 pm via Microsoft Teams. Book your place by clicking on this link Lunch Collab – Learning Disability and Forensic Service

Takeaways from the sessions will include:

  • Who the Teams are and how to contact them
  • Referral criteria/ Who and how!
  • What they don’t offer and why
  • Signposting for additional help and advice
  • Current wait times
  • Support available for those on our waiting lists and for you
  • Resources referred to in the session for you to share with your colleagues and Teams

You will also have the opportunity to ask those questions that can help us all to work more collaboratively through a shared understanding of roles and services provided across primary and secondary care.

The lunchtime sessions are designed for GP colleagues but please feel free to extend the invitation to anyone else in your Teams who might benefit from coming together with RDaSH services , for example Care Navigators, clinical staff, PCN staff, Social Prescribers, etc.                                                                                      

Please share across your GP, Clinical and Admin Teams as you feel appropriate.

Our last session was rated 5 out of 5 and ALL of those who fed back to us felt that it was a good use of their time.  Why not come and see what Lunch Collab is all about?

Date

Time

Focus

Ticketline

Tuesday, 16 December

12 noon to 1 pm

Epilepsy Service – Doncaster only

RDaSH Lunch Collab – Epilepsy Service (DONCASTER ONLY) – 16/12/25

Wednesday, 28 January 2026

12 noon to 1 pm

Wheelchair Service – Doncaster only

RDaSH Lunch Collab – Wheelchair Service (DONCASTER ONLY) – 28/1/26

Thursday, 19 February

12 noon to 1 pm

CAMHS – Getting Advice – All localities

RDaSH Lunch Collab – CAMHS Getting Advice – 19/2/26

Tuesday, 17 March

12 noon to 1 pm

Zone 5-19 – School Nursing, Sexual Health and Substance Misuse – Doncaster only

RDaSH Lunch Collab – Zone 5-19 (DONCASTER) – 17/3/26

For further information please contact Cheryl Gowland

GP Liaison

Visit us at X @RDaSH_GPLiaison

Nurse Verification of Death - New Coroner Process

From 1 January 2026, a new process will be introduced in Doncaster and across RDaSH services for the verification of expected deaths that are reportable to the coroner. This follows 18 months of collaborative work between Heidi Atkinson, Nurse Consultant in Specialist Palliative Care, and the coroner’s office to improve the way formal identification is managed in community settings.

At present, when an expected death is reportable to the coroner, the police are required to attend in order to provide formal identification. This has often caused delays and added distress for families. Under the new system, where patients have been known to community nursing teams for end‑of‑life care, nurses will now be able to lead the identification process, supported by relatives and funeral directors.

The agreed procedure will involve three witness statements:

  • A nurse’s witness statement confirming identification.
  • A relatives’ or carers’ witness statement, completed with the nurse’s support.
  • A funeral director’s witness statement, provided by the coroner‑appointed funeral director.

This mirrors the process already in place within hospice inpatient units and represents a significant step forward in recognising the role of nurses in community end‑of‑life care. Training packages have been developed for unplanned care nurses to ensure confidence and consistency, and funeral directors have also received training to adapt their practice to the community setting.

While this process will initially apply to RDaSH nurses only, the coroner has indicated openness to discussions with other agencies in the future. The forms used have been designed specifically for RDaSH and nursing visits, but the work undertaken could help shape wider adoption across the system.

This change is expected to reduce delays, ease pressure on police resources, and provide families with a more compassionate and timely process at a difficult time. Formal communication will be shared closer to the launch date, but colleagues should be aware that this new pathway will be operational from January 2026.

Introduction of a Routine Varicella Vaccination Programme

The Joint Committee on Vaccination and Immunisation (JCVI) has formally recommended the inclusion of varicella (chickenpox) vaccination within the national childhood immunisation schedule. This marks a significant development in the UK’s approach to preventing a common but potentially serious childhood illness.

Key Details of the Programme

  • Start date: From 1 January 2026, the varicella vaccine will be introduced into the routine programme.
  • Vaccine type: Children will receive the combined measles, mumps, rubella and varicella (MMRV) vaccine, rather than a standalone varicella dose.
  • Schedule:
    • First dose: At 12 months of age (alongside other routine immunisations).
    • Second dose: At 18 months of age, ensuring strong and lasting protection.
  • Catch-up provision: A structured catch-up programme will be available for children up to the age of 6 years, ensuring those who missed earlier doses can still benefit.

Rationale and Impact

  • Public health benefit: Varicella is usually mild but can cause complications, particularly in vulnerable groups. Routine vaccination is expected to reduce circulation of the virus, lower hospital admissions, and prevent outbreaks.
  • Integration with existing programme: By combining varicella with MMR, the schedule remains streamlined, minimising additional appointments and improving uptake.
  • Equity of access: The catch-up programme ensures children who may have missed early vaccination opportunities are not disadvantaged.

Next Steps for Practices

  • Awareness: Practices should familiarise themselves with the updated schedule and prepare to discuss the benefits of the MMRV vaccine with parents and carers.
  • Implementation: NHS England has confirmed that detailed guidance, training materials, and supply arrangements will be circulated ahead of the January 2026 launch.
  • Communication: Clear, accessible information will be essential to support parental understanding and confidence, particularly around the combined vaccine.

Cameron Fund Christmas Appeal

Please take a moment to read the letter from the treasurer, Dr Simon Parkinson, which gives details of the Cameron Fund’s Christmas Appeal for 2025 and the excellent work that the Cameron Fund does.  Doncaster LMC supports the fund and gives an annual donation.

http://www.cameronfund.org.uk/news/2025-christmas-appeal

Recruitment of Medical Appraisers – North East & Yorkshire

NHS England (North East & Yorkshire) has announced that recruitment is now open for Medical Appraiser roles across the region. This is an important opportunity for experienced GPs to contribute to the delivery of high‑quality medical appraisal, supporting professional development and ensuring appraisal standards are maintained across general practice.

Medical Appraisers play a vital role in guiding colleagues through the appraisal process, helping them reflect on their practice, identify learning needs, and plan ongoing professional development. The role is central to maintaining clinical standards and supporting the wellbeing and career progression of doctors in our region.

Expressions of interest are invited, with the deadline set for 1 December 2025. However, NHS England has advised that if a large number of applications are received, recruitment may close earlier, so interested colleagues are encouraged to apply promptly. The vacancy advert and expression of interest form have been circulated alongside this notice.

For further information or queries, colleagues can contact the Professional Standards team directly at england.neyprofessionalstandards@nhs.net. The recruitment process is being overseen by Leanne Edwards, Professional Standards Manager, who can be reached via leanne.edwards1@nhs.net.

This is a valuable chance for GPs to step into a role that not only supports peers but also strengthens the appraisal system across our region. We would encourage anyone with an interest in medical education, professional development, and appraisal to consider submitting an expression of interest.

NEY Medical Appraiser Expression of interest form

Updated Referral Form - Tier 3 Weight Management Service

Colleagues are advised that the Referral Form for the Oviva Consultant‑led remote Tier 3 Weight Management service has now been updated within both Emis Web and SystmOne. The form remains in the same location as before, but practices should ensure they are using the latest version, as eligibility and exclusion criteria have recently changed.

From 24 October 2025, South Yorkshire ICB introduced stricter eligibility criteria for access to Tier 3 support. Patients must now meet one of the following thresholds:

  • A BMI of 50 kg/m² or above;
  • A BMI of 40 kg/m² or above with at least four weight‑related co‑morbidities (hypertension, dyslipidaemia, obstructive sleep apnoea, atherosclerotic cardiovascular disease, or type 2 diabetes mellitus);
  • Transition of care for young people from Complications of Excess Weight (CEW) services, regardless of BMI;
  • An adjusted threshold of 2.5 kg/m² lower for patients from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African‑Caribbean backgrounds, as well as those of mixed heritage including these groups, to ensure equitable access.

Practices should also note that there have been changes to the exclusion criteria, which are detailed in the updated referral form.

Despite the tighter thresholds, there remains a significant cohort of patients who qualify for Tier 3 support and who could benefit greatly from this personalised programme. The service is designed to make referrals straightforward and to give clinicians confidence in identifying eligible patients.

Why this matters

Referring patients now ensures they can access a free NHS programme that offers:

  • Consultant‑led, multidisciplinary care from doctors, dietitians, and psychologists;
  • Tailored support to help patients make lasting changes to diet, activity, and wellbeing;
  • Flexible, remote access via app or telephone, with language support where needed;
  • Access to weight‑loss medication (including Wegovy/GLP‑1 injections) for eligible patients;
  • Behaviour change coaching to support sustainable, long‑term results.

This service represents a valuable opportunity to support patients with complex weight‑related needs, improve health outcomes, and reduce the burden of obesity‑related illness across our communities.

Oviva-T3WM-Referral-Form-South-Yorkshire-V3

Message from the BMA - England Dispute Over Contract Changes

The BMA would like to remind colleagues that support for any practice in relation to the contract changes and more information and guidance about the dispute, including template letters BMA+Template+Letter+from+GP+practices+to+ICBs+regarding+1st+October+changes+to+contract+on+online+consultations about safeguarding measures, is available here: Campaigning around GP contracts in England.

The BMA advise that being in dispute does NOT mean practices can ignore the contractual changes being implemented on 1 October 2025, nor can GPC England, or LMCs, recommend or endorse such an approach. Declaring a dispute is akin to declaring compliance with the new contractual requirements in the 25/26 contract agreement in March 2025, but “under protest” GP contract changes England 2025/26

Therefore, practices must:

  • have an online consultation tool, which is available to registered patients throughout core hours (8am – 6.30pm), to allow them to make non urgent / routine appointments requests, medication queries and administrative requests and
  • ensure GP Connect (Update Record) write access functionality is enabled.

The BMA have also updated their FAQs for 1 October 2025 online consultations. https://cdn.intelligencebank.com/eu/share/qMbw14/NZMLN/JYMlz/original/BMA+FAQs+for+1+October+2025+online+consultations+26.09.2025

 GPC England and many LMCs are aware that both NHS England and ICBs may be undertaking assurance measures. As the BMA prepare for further escalatory options, the BMA encourage any GPs or GP registrars who are not BMA members to join so that they may vote in any potential future ballot and ensure membership information is up to date.

GPC England is now considering the BMA’s options and what their next steps should be.  Access all BMA guidance: https://www.bma.org.uk/our-campaigns/gp-campaigns/england/campaigning-around-gp-contracts-in-england

LMC Buying Group

Doncaster LMC is been a member of the LMC Buying Groups Federation.

Buying Group membership entitles practices to discounts on products and services provided by the Buying Group’s suppliers.

Membership is free and there is no obligation on practices to use all the suppliers. However, practices can save thousands of pounds a year just by switching to Buying Group suppliers. To view the pricing and discounts on offer you need to register for access to the Buying Group’s online portal: https://buying.plexusportal.co.uk/Register.

What is the purpose of the Buying Group and how does it work?

The sole purpose of the Buying Group is to save its member practices money by negotiating discounts on goods and services which practices regularly purchase. The Buying Group team negotiate with suppliers, after which they identify ‘approved’ suppliers, who guarantee to give you significant discounts over what you would otherwise pay for their services, in return for the Buying Group’s endorsement and help in making you aware of what they offer.

Does it cost us anything to be part of the group?

No, membership is free and members are free to use as many discounts as they wish.

Is there any obligation to take up the deals offered?

No. Each practice is free to take up or decline any of the deals the Buying Group have negotiated. If you wish to take advantage of any of the offers in question, you will be given contact details, and all communications take place between you and the individual supplier*.

*The Buying Group accepts no liability for any contract willingly entered into by a practice with an approved supplier. Practices are advised to check that the terms of any contract with suppliers are consistent with those the Buying Group have negotiated and are advised to inform the Buying Group team of any discrepancy. The Buying Group do not, however, accept any responsibility for any member practices’ failure to check the terms of the relevant contract and the principle of caveat emptor (buyer beware) applies in all cases. Your rights as a consumer under the Consumer Protection Act are unaffected. With respect to any services to which the provisions of the Financial Services Act 2000 might apply practices are advised to seek independent financial advice as may be appropriate.

What happens to my details?

When a practice signs up for Buying Group membership, they will keep your basic contact details (practice address) on a secure system. On the membership application form, they also ask you how they can use your personal data (i.e. your email address) but even if you do sign up to receive their emails you can stop them at any time by clicking the unsubscribe button.

What if I am not happy with the quality of goods and services supplied?

Always let the Buying Group know if you encounter any problems getting what you want, and they will endeavour to sort it out.

Contact the Buying Group

The Buying Group is managed by Plexus Support Services Ltd:

Tel: 0115 979 6910

Email: info@plexussupport.co.uk

Website: https://www.plexussupport.co.uk

Call Now Button